Atrin Pharmaceuticals LLC has a total of 14 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CHAKRAVARTY SARVAJIT, CRINETICS PHARMACEUTICALS INC and ABBISKO THERAPEUTICS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Gilad Oren | 11 |
#2 | Breslin Henry Joseph | 11 |
#3 | Oren Gilad | 2 |
#4 | Brown Eric J | 2 |
#5 | Sperl Gerhard | 2 |
#6 | Henry Joseph Breslin | 2 |
#7 | Butler Laura | 2 |
Publication | Filing date | Title |
---|---|---|
US2017291911A1 | Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their use | |
CA2963973A1 | Ataxia telengiectasia and rad3-related (atr) protein kinase inhibitors |